Name:
Institution:
Type:
PI
Research Objective
Pro-healing biomaterial to treat lung inflammation and promote recovery.
Impact
COVID-19 associated acute respiratory distress syndrome
Major Proposed Activities
In late-June 2020, there are more than 5,700 Californians who are currently hospitalized because of COVID-19 (tested positive or suspected) with over 1,300 confirmed COVID-19 patients in the ICU. A significant number of severe cases involve a negative inflammatory response in the lungs leading to respiratory failure. We aim to develop a new therapeutic that can treat this inflammation and promote lung healing thereby having potential benefit to thousands of Californians.